Search results
Proton pump inhibitors (PPIs) have the best clinical profile for symptomatic management (Recommendation grade A). Antireflux surgery is not superior to pharmacological acid suppression for the prevention of neoplastic progression of Barrett's oesophagus (Recommendation grade C).
treated by endoscopic resection, provided that adequate follow-up with gastroscopy, endoscopic ultrasound (EUS), and computed tomography (CT)/positrion emission tomo-graphy-computed tomography (PET-CT) is performed in expertcenters. Weak recommendation, low quality of evidence. MR9 ESGE suggests that submucosal (T1b) esophageal
Barrett’s oesophagus? 5. How should we best manage dysplasia in Barrett’s oesophagus? 6. Which staging modality is preferred for Barrett’s-related early OAC? 7. What are the indications for endoscopic and/ or surgical therapy in Barrett’s-related adenocarcinoma? 8. Are there minimum standards for training and
Long-term outcomes of patients with Barrett’s esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Gastrointestinal endoscopy.
23 mar 2023 · The management of patients with Barrett’s esophagus still poses several clinical issues to the clinician, from correctly defining diagnosis to choosing adequate treatment. This brief and evidence-based review is aimed at providing a practical guide for the adequate management of this condition.
8 lut 2023 · This guideline covers monitoring, treatment and follow-up for people aged 18 and over with Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma. It includes advice on endoscopic and non-endoscopic techniques.
1 gru 2016 · Endoscopic therapy is safe and effective for the treatment of dysplastic BE and intramucosal EAC, but ongoing surveillance following treatment is necessary. This review will cover screening, surveillance, advanced imaging, chemoprevention, endoscopic treatment, and post-treatment surveillance of BE.
